Skip to content

Drug interactions

Ceritinib + Dexlansoprazole

Severity: Minor

Ceritinib and Dexlansoprazole: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ceritinib inhibits CYP3A4, which has a minor role in dexlansoprazole clearance. Dexlansoprazole exposure may rise somewhat, but a clinically significant effect is unlikely. Ceritinib's own absorption is pH-dependent, particularly when taken fasted.

What this interaction means in plain words

Ceritinib and Dexlansoprazole have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Ceritinib belongs to Oncology; Dexlansoprazole belongs to Gastrointestinal Tract.

Evidence level: Low

Why it happens

Ceritinib inhibits CYP3A4, a secondary pathway for dexlansoprazole metabolism.

What to do

No dose change is needed. Monitor for dexlansoprazole adverse effects and ceritinib efficacy.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ceritinib and Dexlansoprazole, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ceritinib with Dexlansoprazole?

MediHelp rates the interaction as minor. Ceritinib and Dexlansoprazole have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Ceritinib inhibits CYP3A4, which has a minor role in dexlansoprazole clearance. Dexlansoprazole exposure may rise somewhat, but a clinically significant effect is unlikely. Ceritinib's own absorption is pH-dependent, particularly when taken fasted.

How serious is the interaction between Ceritinib and Dexlansoprazole?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is needed. Monitor for dexlansoprazole adverse effects and ceritinib efficacy.

What other medicines interact with Dexlansoprazole?

MediHelp also lists interactions of Dexlansoprazole with, for example, Mavacamten, Rilpivirine, Acalabrutinib. The full list is on the Dexlansoprazole page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in